![Larimar Therapeutics Inc](/common/images/company/N_LRMR.png)
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion p... Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.2325 | 29.1830065359 | 7.65 | 9.84 | 7.45 | 701594 | 8.70423766 | CS |
4 | 0.2125 | 2.19751809721 | 9.67 | 10.2 | 6.8 | 528467 | 8.11464108 | CS |
12 | 2.9225 | 41.9899425287 | 6.96 | 10.2 | 5.91 | 500256 | 8.01314302 | CS |
26 | 5.3325 | 117.197802198 | 4.55 | 13.68 | 4.09 | 549787 | 8.93529398 | CS |
52 | 6.5825 | 199.46969697 | 3.3 | 13.68 | 2.18 | 355208 | 7.71011831 | CS |
156 | -1.6975 | -14.6588946459 | 11.58 | 15.2581 | 1.53 | 226875 | 6.20299807 | CS |
260 | -2.1175 | -17.6458333333 | 12 | 25.87 | 1.53 | 188292 | 7.07984068 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.